LEVO THERAPEUTICS Trademark

Trademark Overview

On Wednesday, April 7, 2021, a trademark application was filed for LEVO THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the LEVO THERAPEUTICS trademark a serial number of 90628691. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Monday, March 18, 2024. This trademark is owned by Levo Therapeutics, Inc.. The LEVO THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products and preparations for the treatment of Prader-Willi syndrome (PWS) and related disorders; pharmaceutical products and preparations for the treatment of neurodevelopmental and metabolic disorders
levo therapeutics

General Information

Serial Number90628691
Word MarkLEVO THERAPEUTICS
Filing DateWednesday, April 7, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateMonday, March 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 8, 2022

Trademark Statements

Goods and ServicesPharmaceutical products and preparations for the treatment of Prader-Willi syndrome (PWS) and related disorders; pharmaceutical products and preparations for the treatment of neurodevelopmental and metabolic disorders
Disclaimer with Predetermined Text"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 14, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLevo Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSkokie, IL 60077
Party NameLevo Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSkokie, IL 60077

Trademark Events

Event DateEvent Description
Tuesday, March 19, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 18, 2024SOU EXTENSION 4 GRANTED
Monday, March 18, 2024SOU EXTENSION 4 FILED
Monday, March 18, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, September 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 11, 2023SOU EXTENSION 3 GRANTED
Monday, September 11, 2023SOU EXTENSION 3 FILED
Monday, September 11, 2023SOU TEAS EXTENSION RECEIVED
Friday, March 17, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 15, 2023SOU EXTENSION 2 GRANTED
Wednesday, March 15, 2023SOU EXTENSION 2 FILED
Wednesday, March 15, 2023SOU TEAS EXTENSION RECEIVED
Monday, November 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, November 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 9, 2022SOU EXTENSION 1 GRANTED
Friday, September 9, 2022SOU EXTENSION 1 FILED
Friday, September 9, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, April 5, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 8, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 8, 2022PUBLISHED FOR OPPOSITION
Monday, January 31, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 31, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, January 31, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 19, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 6, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 6, 2022EXAMINER'S AMENDMENT ENTERED
Thursday, January 6, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, January 6, 2022EXAMINERS AMENDMENT E-MAILED
Thursday, January 6, 2022EXAMINERS AMENDMENT -WRITTEN
Sunday, November 28, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, November 28, 2021NON-FINAL ACTION E-MAILED
Sunday, November 28, 2021NON-FINAL ACTION WRITTEN
Sunday, November 28, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, November 28, 2021NON-FINAL ACTION E-MAILED
Sunday, November 28, 2021NON-FINAL ACTION WRITTEN
Tuesday, November 23, 2021ASSIGNED TO EXAMINER
Wednesday, July 14, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 10, 2021NEW APPLICATION ENTERED

Related Keywords

therapeutics levo pharmaceutical disorders treatment products preparations neurodevelopmental metabolic willi prader syndrome